Cdk2/Cyclin Inhibitory Peptide I

Modify Date: 2024-01-17 17:47:07

Cdk2/Cyclin Inhibitory Peptide I Structure
Cdk2/Cyclin Inhibitory Peptide I structure
Common Name Cdk2/Cyclin Inhibitory Peptide I
CAS Number 237392-84-6 Molecular Weight 2571.05
Density N/A Boiling Point N/A
Molecular Formula C111H196N48O23 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Cdk2/Cyclin Inhibitory Peptide I


Cdk2/Cyclin Inhibitory Peptide I (Tat-LFG), a CDK2 inhibitor, kills U2OS osteosarcoma cells in a dose-dependent manner[1].

 Names

Name Cdk2/Cyclin Inhibitory Peptide I

 Cdk2/Cyclin Inhibitory Peptide I Biological Activity

Description Cdk2/Cyclin Inhibitory Peptide I (Tat-LFG), a CDK2 inhibitor, kills U2OS osteosarcoma cells in a dose-dependent manner[1].
Related Catalog
Target

CDK2[1].

In Vitro Cdk2/Cyclin Inhibitory Peptide I (0-150 µM; 24 h) kills U2OS osteosarcoma cells in a dose-dependent manner[1]. Cell Viability Assay[1] Cell Line: U2OS osteosarcoma cells Concentration: 0-150 µM Incubation Time: 24 h Result: Exhibited good activity to kill U2OS osteosarcoma cells.

 Chemical & Physical Properties

Molecular Formula C111H196N48O23
Molecular Weight 2571.05